Please enable JavaScript to continue using this application.

Compare $ARQT vs $CDNA | Chartloom

Compare

$ARQT vs $CDNA

Arcutis Biotherapeutics Inc · CareDx Inc

ARQT

Arcutis Biotherapeutics Inc

CDNA

CareDx Inc

Compare $ARQT vs $CDNA

Comparing Arcutis Biotherapeutics Inc and CareDx Inc

ARQTArcutis Biotherapeutics Inc

CDNACareDx Inc

ARQTArcutis Biotherapeutics Inc

Market cap

$3.32B

P/E (TTM)

126.66x

Forward P/E (NTM)

34.71x

Forward P/S (NTM)

5.40x

Rev growth (TTM)

76.1%

YTD performance

-8.3%

52W performance

25.1%

FCF yield

1.2%

CDNACareDx Inc

Market cap

$3.29B

P/E (TTM)

30.64x

Forward P/E (NTM)

57.50x

Forward P/S (NTM)

6.55x

Rev growth (TTM)

34.4%

YTD performance

232.7%

52W performance

330.5%

FCF yield

2.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ARQT

CDNA

Detailed metrics comparison

ARQT

Arcutis Biotherapeutics Inc

CDNA

CareDx Inc

Market Cap

ARQT$3.32B

CDNA$3.29B

Enterprise Value

ARQT$3.40B

CDNA$2.92B

Price

ARQT$26.58

CDNA$63.67

P/E Ratio

ARQT126.66x

CDNA30.64x

P/S Ratio

ARQT7.17x

CDNA7.18x

EV/Sales

ARQT7.33x

CDNA6.36x

EV/EBITDA

ARQT87.53x

CDNA23.24x

P/B Ratio

ARQT14.34x

CDNA8.16x

P/FCF Ratio

ARQT84.92x

CDNA39.14x

EV/FCF

ARQT86.83x

CDNA34.70x

PEG Ratio

ARQTN/A

CDNA0.31x

Forward P/E (NTM)

ARQT34.71x

CDNA57.50x

Forward P/S (NTM)

ARQT5.40x

CDNA6.55x

Revenue (TTM)

ARQT$464M

CDNA$458M

Revenue Growth (YoY)

ARQT76.1%

CDNA34.4%

Forward Rev Growth

ARQT27.7%

CDNA7.0%

Gross Margin (TTM)

ARQT91.1%

CDNA70.6%

Operating Margin (TTM)

ARQT7.4%

CDNA23.6%

EBITDA Margin (TTM)

ARQT7.9%

CDNA27.4%

Net Margin (TTM)

ARQT6.1%

CDNA24.2%

FCF Margin (TTM)

ARQT8.4%

CDNA18.3%

Net Income (TTM)

ARQT$29M

CDNA$111M

FCF (TTM)

ARQT$39M

CDNA$84M

EPS (TTM)

ARQT$0.21

CDNA$2.08

ROE (TTM)

ARQT15.0%

CDNA32.8%

ROA (TTM)

ARQT6.5%

CDNA24.8%

ROIC (TTM)

ARQT9.6%

CDNA32.8%

Cash

ARQT$34M

CDNA$374M

Debt

ARQT$109M

CDNA$0

Net Cash/Debt

ARQT$-75M

CDNA$374M

Current Ratio (TTM)

ARQT2.92x

CDNA4.58x

Quick Ratio (TTM)

ARQT2.46x

CDNA4.35x

Debt/Equity (TTM)

ARQT0.49x

CDNA0.00x

Debt/Assets (TTM)

ARQT0.0%

CDNA0.0%

Interest Coverage (TTM)

ARQTN/A

CDNAN/A

Net Debt/EBITDA (TTM)

ARQT0.00x

CDNA0.00x

Beta

ARQT1.66

CDNA2.58

52W Performance

ARQT25.1%

CDNA330.5%

YTD Performance

ARQT-8.3%

CDNA232.7%

% from 52W High

ARQT-16.3%

CDNA-12.2%

% from 52W Low

ARQT37.8%

CDNA356.4%

Asset Turnover (TTM)

ARQT1.06x

CDNA1.02x

FCF Yield (TTM)

ARQT1.2%

CDNA2.6%

Earnings Yield (TTM)

ARQT0.9%

CDNA3.4%

Dividend Yield (TTM)

ARQTN/A

CDNAN/A

Rule of 40

ARQT84.5

CDNA52.7

EV/GP/RG

ARQT0.23

CDNA0.94

Ticker research

View ARQT research View CDNA research

Metric	ARQT Arcutis Biotherapeutics Inc	CDNA CareDx Inc
Market & Valuation
Market Cap	$3.32B	$3.29B
Enterprise Value	$3.40B	$2.92B
Price	$26.58	$63.67
P/E Ratio	126.66x	30.64x
P/S Ratio	7.17x	7.18x
EV/Sales	7.33x	6.36x
EV/EBITDA	87.53x	23.24x
P/B Ratio	14.34x	8.16x
P/FCF Ratio	84.92x	39.14x
EV/FCF	86.83x	34.70x
PEG Ratio	N/A	0.31x
Forward P/E (NTM)	34.71x	57.50x
Forward P/S (NTM)	5.40x	6.55x
Revenue & Growth
Revenue (TTM)	$464M	$458M
Revenue Growth (YoY)	76.1%	34.4%
Forward Rev Growth	27.7%	7.0%
Profitability
Gross Margin (TTM)	91.1%	70.6%
Operating Margin (TTM)	7.4%	23.6%
EBITDA Margin (TTM)	7.9%	27.4%
Net Margin (TTM)	6.1%	24.2%
FCF Margin (TTM)	8.4%	18.3%
Net Income (TTM)	$29M	$111M
FCF (TTM)	$39M	$84M
EPS (TTM)	$0.21	$2.08
ROE (TTM)	15.0%	32.8%
ROA (TTM)	6.5%	24.8%
ROIC (TTM)	9.6%	32.8%
Financial Health
Cash	$34M	$374M
Debt	$109M	$0
Net Cash/Debt	$-75M	$374M
Current Ratio (TTM)	2.92x	4.58x
Quick Ratio (TTM)	2.46x	4.35x
Debt/Equity (TTM)	0.49x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	2.58
52W Performance	25.1%	330.5%
YTD Performance	-8.3%	232.7%
% from 52W High	-16.3%	-12.2%
% from 52W Low	37.8%	356.4%
Efficiency & Yields
Asset Turnover (TTM)	1.06x	1.02x
FCF Yield (TTM)	1.2%	2.6%
Earnings Yield (TTM)	0.9%	3.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	84.5	52.7
EV/GP/RG	0.23	0.94
Ticker research	View ARQT research	View CDNA research

Valuation

P/E Ratio

CDNA

30.64x

ARQT

126.66x

P/S Ratio

ARQT

7.17x

CDNA

7.18x

EV/FCF

CDNA

34.70x

ARQT

86.83x

Growth & revenue

Revenue Growth TTM

ARQT

76.1%

CDNA

34.4%

Forward Revenue Growth

ARQT

27.7%

CDNA

7.0%

Profitability & performance

Gross Margin

ARQT

91.1%

CDNA

70.6%

ROE

CDNA

32.8%

ARQT

15.0%

FCF Yield %

CDNA

2.6%

ARQT

1.2%

52-Week Performance

CDNA

330.5%

ARQT

25.1%

Detailed metrics comparison

ARQT

Arcutis Biotherapeutics Inc

CDNA

CareDx Inc

Market Cap

ARQT$3.32B

CDNA$3.29B

Enterprise Value

ARQT$3.40B

CDNA$2.92B

Price

ARQT$26.58

CDNA$63.67

P/E Ratio

ARQT126.66x

CDNA30.64x

P/S Ratio

ARQT7.17x

CDNA7.18x

EV/Sales

ARQT7.33x

CDNA6.36x

EV/EBITDA

ARQT87.53x

CDNA23.24x

P/B Ratio

ARQT14.34x

CDNA8.16x

P/FCF Ratio

ARQT84.92x

CDNA39.14x

EV/FCF

ARQT86.83x

CDNA34.70x

PEG Ratio

ARQTN/A

CDNA0.31x

Forward P/E (NTM)

ARQT34.71x

CDNA57.50x

Forward P/S (NTM)

ARQT5.40x

CDNA6.55x

Revenue (TTM)

ARQT$464M

CDNA$458M

Revenue Growth (YoY)

ARQT76.1%

CDNA34.4%

Forward Rev Growth

ARQT27.7%

CDNA7.0%

Gross Margin (TTM)

ARQT91.1%

CDNA70.6%

Operating Margin (TTM)

ARQT7.4%

CDNA23.6%

EBITDA Margin (TTM)

ARQT7.9%

CDNA27.4%

Net Margin (TTM)

ARQT6.1%

CDNA24.2%

FCF Margin (TTM)

ARQT8.4%

CDNA18.3%

Net Income (TTM)

ARQT$29M

CDNA$111M

FCF (TTM)

ARQT$39M

CDNA$84M

EPS (TTM)

ARQT$0.21

CDNA$2.08

ROE (TTM)

ARQT15.0%

CDNA32.8%

ROA (TTM)

ARQT6.5%

CDNA24.8%

ROIC (TTM)

ARQT9.6%

CDNA32.8%

Cash

ARQT$34M

CDNA$374M

Debt

ARQT$109M

CDNA$0

Net Cash/Debt

ARQT$-75M

CDNA$374M

Current Ratio (TTM)

ARQT2.92x

CDNA4.58x

Quick Ratio (TTM)

ARQT2.46x

CDNA4.35x

Debt/Equity (TTM)

ARQT0.49x

CDNA0.00x

Debt/Assets (TTM)

ARQT0.0%

CDNA0.0%

Interest Coverage (TTM)

ARQTN/A

CDNAN/A

Net Debt/EBITDA (TTM)

ARQT0.00x

CDNA0.00x

Beta

ARQT1.66

CDNA2.58

52W Performance

ARQT25.1%

CDNA330.5%

YTD Performance

ARQT-8.3%

CDNA232.7%

% from 52W High

ARQT-16.3%

CDNA-12.2%

% from 52W Low

ARQT37.8%

CDNA356.4%

Asset Turnover (TTM)

ARQT1.06x

CDNA1.02x

FCF Yield (TTM)

ARQT1.2%

CDNA2.6%

Earnings Yield (TTM)

ARQT0.9%

CDNA3.4%

Dividend Yield (TTM)

ARQTN/A

CDNAN/A

Rule of 40

ARQT84.5

CDNA52.7

EV/GP/RG

ARQT0.23

CDNA0.94

Ticker research

View ARQT research View CDNA research

Metric	ARQT Arcutis Biotherapeutics Inc	CDNA CareDx Inc
Market & Valuation
Market Cap	$3.32B	$3.29B
Enterprise Value	$3.40B	$2.92B
Price	$26.58	$63.67
P/E Ratio	126.66x	30.64x
P/S Ratio	7.17x	7.18x
EV/Sales	7.33x	6.36x
EV/EBITDA	87.53x	23.24x
P/B Ratio	14.34x	8.16x
P/FCF Ratio	84.92x	39.14x
EV/FCF	86.83x	34.70x
PEG Ratio	N/A	0.31x
Forward P/E (NTM)	34.71x	57.50x
Forward P/S (NTM)	5.40x	6.55x
Revenue & Growth
Revenue (TTM)	$464M	$458M
Revenue Growth (YoY)	76.1%	34.4%
Forward Rev Growth	27.7%	7.0%
Profitability
Gross Margin (TTM)	91.1%	70.6%
Operating Margin (TTM)	7.4%	23.6%
EBITDA Margin (TTM)	7.9%	27.4%
Net Margin (TTM)	6.1%	24.2%
FCF Margin (TTM)	8.4%	18.3%
Net Income (TTM)	$29M	$111M
FCF (TTM)	$39M	$84M
EPS (TTM)	$0.21	$2.08
ROE (TTM)	15.0%	32.8%
ROA (TTM)	6.5%	24.8%
ROIC (TTM)	9.6%	32.8%
Financial Health
Cash	$34M	$374M
Debt	$109M	$0
Net Cash/Debt	$-75M	$374M
Current Ratio (TTM)	2.92x	4.58x
Quick Ratio (TTM)	2.46x	4.35x
Debt/Equity (TTM)	0.49x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	2.58
52W Performance	25.1%	330.5%
YTD Performance	-8.3%	232.7%
% from 52W High	-16.3%	-12.2%
% from 52W Low	37.8%	356.4%
Efficiency & Yields
Asset Turnover (TTM)	1.06x	1.02x
FCF Yield (TTM)	1.2%	2.6%
Earnings Yield (TTM)	0.9%	3.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	84.5	52.7
EV/GP/RG	0.23	0.94
Ticker research	View ARQT research	View CDNA research